Live Breaking News & Updates on Intensify Business

Sickle Cell Disease Treatment Market to Exhibit a CAGR of 18.5% and Reach USD 7.71 Billion by 2027; FDA Approval for Emmaus’s Endari to Aid Development, states Fortune Business Insights™
Key Prominent Players Covered in the Sickle Cell Disease Treatment Market Research Report Are Novartis AG (Basel, Switzerland), Global Blood Therapeutics Inc. (California, U.S.), Emmaus Medical Inc. (California, U.S.), Addmedica (Paris, France), Medunik USA Inc. (Pennsylvania, U.S.), Bristol-Myers Squibb Company (New York City, U.S.) and other key market players.
January 20, 2021 08:56 ET
| Source:
Fortune Business Insights
Fortune Business Insights
Pune, India, Jan. 20, 2021 (GLOBE NEWSWIRE) The
global sickle cell disease treatment market size is expected to reach USD 7.71 billion in 2027, exhibiting a CAGR of 18.5% during the forecast period. The unmet needs of patients and lack of novel therapies has resulted in rese ....

Saudi Arabia , United States , United Arab Emirates , American Red Cross Blood Services , Bristol Myers Squibb Company New York City , Marrow Transplant Research , International Blood , Medunik United States Inc , Research Scope , Sickle Cell Disease Treatment Market Research , Emmaus Medical Inc , Overview Of Sickle Cell Disease Treatment Services , Major Sickle Cell Disease Treatment Service Providers , Key Development , Emmaus Life Sciences , Research Methodology , A Sample Copy Of The Research , Global Blood Therapeutics Inc , Endari Emmaus Life Sciences , Fortune Business Insights , Cell Disease Treatment Market Size , Treatment Modality , Bone Marrow Transplant , Blood Transfusion , Branded Drugs , End User ,